The landscape of weight management is changing dramatically with the emergence of several novel injectable therapies. the GLP-1/GIP dual agonist, Cagrilintide , Survodutide , and a GLP-1 receptor agonist https://nexaphresearchpeptides.com/product-category/research-products/